Yeah went pretty well. Mostly high level and introdctory for newcomers to the story, but a good recap and PR did pretty well. The only takeaway I got is that I'm a little more comfortable that the 2mg x 2 regime should sail through, just given the language around the extent of the extra preclinical testing and that it almost appeared to have been done at the request of the FDA should we need to revert to 2x2 (I'm not sure - would like to listen to the playback).
A small highlight was from the Bells guy who asked about IP and manufacturing exclusivity which is an important element given "this could be the biggest selling drug in the world"!
Yeah went pretty well. Mostly high level and introdctory for...
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 28.0¢ | $51.57K | 182.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 76003 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 125891 | 5 |
View Market Depth
| Last trade - 12.51pm 03/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |